Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Calculus Vct Plc | CLC | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 58.00 | 00:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 58.00 | 58.00 | 58.00 | 58.00 | 58.00 |
| Industry Sector |
|---|
| EQUITY INVESTMENT INSTRUMENTS |
| Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
| 11/07/2024 | Final | GBP | 0.0277 | 08/08/2024 | 09/08/2024 | 29/08/2024 |
| 30/06/2023 | Final | GBP | 0.0295 | 27/07/2023 | 28/07/2023 | 25/08/2023 |
| 01/06/2022 | Final | GBP | 0.0306 | 30/06/2022 | 01/07/2022 | 29/07/2022 |
| 21/05/2021 | Final | GBP | 0.0302 | 01/07/2021 | 02/07/2021 | 30/07/2021 |
| 27/05/2020 | Final | GBP | 0.032 | 02/07/2020 | 03/07/2020 | 31/07/2020 |
| Top Posts |
|---|
Posted at 12/10/2010 06:33 by 22hoper The Hydra Management part of the company is generating good cash and with new contracts things are looking up for clc. |
Posted at 01/7/2007 10:28 by rolfe and nolan I expect to see CLC trading in double figures this coming week. CLC will now bear the fruit of it's labours. |
Posted at 29/6/2007 12:01 by orange1 Well, I never ....We've only gone out and won ourselves another contract! Let the mad buying frenzy begin. Today's AGM Statement in full: "Since the Company began its restructuring plan in the first half of 2005 the Group has reported steady progress with its operations and improving financial performance with losses decreasing steadily over each of the subsequent reporting periods. The following trading areas were noted by Howard Kitchner, Chairman: * The Company is expecting to report comparative period on period improvements to top line revenues for the six month period to 30 June 2007. This is in spite of the significant weakening of the US dollar, over the comparative periods. * During the first half of 2007 the Company has seen its US and Australian operations generating cash. At the present time the Company continues to fund its UK operations with debt. * Since the announcement of our 2006 final results on 27 April 2007, the Group has won a contract in the US to support the renal service department of a hospital with CLINIICAL VISION. Additionally, two customers have completed the implementation of CLINCIAL VISION. * The Group is now working through eight active CLINICAL VISION implementations, with a future revenue opportunity of over #1,000,000. * With respect to the UK market, the Company continues to build partnerships and work with our UK customer base on an upgrade programme from PROTON to CLINICAL VISION. With these trading conditions in mind the Board remains confident about the Group's prospects and continues to view the future with optimism." P.S. What good typists they have over at CLC: is the flagship product called CLINIICAL VISION or CLINCIAL VISION? |
Posted at 29/11/2006 13:18 by orange1 The chairman of CLC has been a big buyer of the shares of late together with a "connected person" substantial shareholder David Altschuler. The chairman Howard Kitchner is a Chartered Accountant who has worked in merchant banking, investment banking and the leasing industry. He is currently chairman of National Leasing & Finance Co. David Altschuler is also a chartered accountant and also at National Leasing & Finance Co. Back in the early 90s the two of them had a brief career as film producers (Leon the Pig Farmer with walk on parts to boot). If I were one of ADVFN's more notorious rampers I would be suggesting that this can only mean one thing: that United Pictures or Time Warner (pick your film producer of choice) are about to reverse into CLC and that now is the time to fill your boots before the rest of the world catches on. LOL! |
Posted at 24/5/2006 19:51 by orange1 "At the top of our list for a dialysis clinical application was a system that would enable us to continue delivering a high quality of care to our patients while improving efficiency and reducing costs," said Ms. Henry. "There are a number of vendors today who offer similar solutions, but not many with the robust application to enable our delivery of quality care to our patients." A tribute to CLC from Scott & White Hospital in Texas which has completed its implementation of CLC's Clinical Vision patient management solution at its three artificial kidney units. For more go to: |
Posted at 02/5/2006 11:53 by chessman2 Clearly Neil Mendoza knew what he was doing when he bought 250,000 shares at 5p.As some of the directors recently put more money into CLC, I would suggest that at last CLC is beginning to look interesting. More exciting news to follow soon? |
Posted at 28/4/2006 19:09 by chessman2 Mendoza is of course an esteemed and illustrious name. I only hope he knows more of CLC than I do.In any event the recent buying must be a sign of high expectations so I will remain on the share register until we get taken out. Now, that would be good!! |
Posted at 27/4/2006 09:11 by orange1 IanLuckily CLC is not my only share! It's now my "Dell Boy" share - "one day we will be millionaires". But just like Dell Boy once made it to millionaire status, it is not beyond the bounds of possibility that the fortunes of CLC could dramatically improve. A few million quids worth of licence fee revenue in one year has been on the cards for many years and still is as far as I am concerned. That would translate to EPS of several pennies. Granted, the chances of this coming to pass appear to be getting ever smaller but they do exist. I am prepared to take the gamble in the knowlegde that the gamble of the director and shareholders, with their personal guarantees,is considerably larger than mine. |
Posted at 23/3/2006 10:16 by orange1 BakuninWelcome! I can't quite believe that somebody is actually interested in this minnow. The £1.25m annual revenue in maintenance fees which I have previously mentioned is based on the figure in the notes to the most recent annual accounts £1.1m uplifted so as to reflect the new contracts. CLC have a large stable customer base who pay maintenance fees every year. Not all of these were originally sold CLC products. A chunk of these customers were acquired in the 90s when CLC acquired them from Fresenius (from memory). I agree that it is unlikely that these are paying 17.5% of the licence fee. It is probably a much lower percentage. But for those acquiring CV4 a rate of 15 to 17.5% is not unreasonable I believe. The CV4 licence fees are higher than 50k but, as you say, there have not been many. It has always been the case with CLC that a spate of licences sold would transform the fortunes of the company. Just £1m to £2m of licences sold in one year woulld have done the trick. But sadly this has never come to pass. Based on the figures last September, the company's financial situation and prospects did not seem to warrant the rock bottom rating we have today. But there has been no news since then and the price today tells its own sad story. I still hold but much more in hope than expectation. The upcoming results should tell us more. |
Posted at 01/2/2006 14:08 by chessman2 CLC do not appear to have been one of my better investments. Thank goodness I am now heavily into oil.If I did not know better I would guess that the expected contracts have not been signed and that the few people in the know are selling a small number of their shares. As we all know if you have too many shares in a stock like this it is nigh on impossible to sell them. And to think that Techinvest thought CLC was good value as well!! Lets hope the market is wrong and that CLC get taken out next week!! |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
